CWBR logo

CohBar (CWBR) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

15 December 2017

Indexes:

Not included

Description:

CohBar, Inc. is a biotechnology company focused on developing therapies for age-related diseases. They use a unique approach by studying mitochondrial peptides, which are small proteins that can help improve health and longevity. Their goal is to create innovative treatments to enhance the quality of life as people age.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 26, 2024

Recent annual earnings:

Mar 30, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sept 23, 2022

Analyst ratings

Recent major analysts updates

11 Aug '21 WBB Securities
Buy
23 Apr '21 Maxim Group
Buy
15 Mar '21 Aegis Capital
Buy
17 Dec '20 Chardan Capital
Buy
15 Oct '20 WBB Securities
Speculative Buy
17 Sept '20 Roth Capital
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Why Is CohBar (CWBR) Stock Up 130% Today?
Why Is CohBar (CWBR) Stock Up 130% Today?
Why Is CohBar (CWBR) Stock Up 130% Today?
CWBR
InvestorPlace23 May 2023

CohBar (NASDAQ: CWBR ) stock is soaring higher on Tuesday after the company announced a planned merger with Morphogenesis . CohBar and Morphogenesis are planning for an all-stock merger that will see the two combine to create a new company named “TuHURA Biosciences, Inc.” This company will continue to trade its shares on The Nasdaq Capital Market.

FAQ

  • What is the primary business of CohBar?
  • What is the ticker symbol for CohBar?
  • Does CohBar pay dividends?
  • What sector is CohBar in?
  • What industry is CohBar in?
  • What country is CohBar based in?
  • When did CohBar go public?
  • Is CohBar in the S&P 500?
  • Is CohBar in the NASDAQ 100?
  • Is CohBar in the Dow Jones?
  • When was CohBar's last earnings report?
  • When does CohBar report earnings?
  • Should I buy CohBar stock now?

What is the primary business of CohBar?

CohBar, Inc. is a biotechnology company focused on developing therapies for age-related diseases. They use a unique approach by studying mitochondrial peptides, which are small proteins that can help improve health and longevity. Their goal is to create innovative treatments to enhance the quality of life as people age.

What is the ticker symbol for CohBar?

The ticker symbol for CohBar is NASDAQ:CWBR

Does CohBar pay dividends?

No, CohBar does not pay dividends

What sector is CohBar in?

CohBar is in the Healthcare sector

What industry is CohBar in?

CohBar is in the Biotechnology industry

What country is CohBar based in?

CohBar is headquartered in United States

When did CohBar go public?

CohBar's initial public offering (IPO) was on 15 December 2017

Is CohBar in the S&P 500?

No, CohBar is not included in the S&P 500 index

Is CohBar in the NASDAQ 100?

No, CohBar is not included in the NASDAQ 100 index

Is CohBar in the Dow Jones?

No, CohBar is not included in the Dow Jones index

When was CohBar's last earnings report?

CohBar's most recent earnings report was on 26 November 2024

When does CohBar report earnings?

The date for CohBar's next earnings report has not been announced yet

Should I buy CohBar stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions